TREYESCAN: configuration of an eye tracking test for the measurement of compensatory eye movements in patients with visual field defects.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
12
07
2023
accepted:
14
11
2023
medline:
27
11
2023
pubmed:
23
11
2023
entrez:
22
11
2023
Statut:
epublish
Résumé
The Traffic Eye Scanning and Compensation Analyzer (TREYESCAN) is introduced as an innovative eye tracking test designed to measure compensatory eye movements in individuals with visual field defects. The primary objective of the test is to quantitatively assess and analyze the compensatory eye movements employed by patients with visual field defects while viewing videos of various traffic scenes from the viewpoint of a driver of a passenger car. The filming process involved capturing a wide range of driving conditions and hazards, aiming to replicate real-world scenarios. Specific dynamic areas of interest within these scenes were selected and assessed by a panel of experts on medical and practical fitness to drive. Pilot measurements were conducted on a sample of 20 normally-sighted individuals during two different measurement sessions. The results provide valuable insights into how individuals without visual impairment view the dynamic scenes presented in the test. Moving forward, the TREYESCAN will be used in a case-control study involving glaucoma patients and control subjects, with the goal of further investigating and understanding the mechanisms employed by individuals with glaucoma to compensate for their visual field defects.
Identifiants
pubmed: 37993508
doi: 10.1038/s41598-023-47470-5
pii: 10.1038/s41598-023-47470-5
pmc: PMC10665380
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
20479Subventions
Organisme : Stichting Steunfonds Uitzicht
ID : UZ 2020-2
Informations de copyright
© 2023. The Author(s).
Références
PLoS One. 2010 Mar 16;5(3):e9710
pubmed: 20300522
PLoS One. 2017 Jun 1;12(6):e0178876
pubmed: 28570621
Nature. 2020 Sep;585(7825):357-362
pubmed: 32939066
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Ophthalmol Retina. 2021 Mar;5(3):224-233
pubmed: 32595096
Vision Res. 2005 May;45(11):1349-54
pubmed: 15743605
J Glaucoma. 2018 Jun;27(6):558-565
pubmed: 29613977
Lancet Glob Health. 2017 Dec;5(12):e1221-e1234
pubmed: 29032195
Curr Biol. 2008 Jan 22;18(2):124-8
pubmed: 18191567
PLoS One. 2014 Feb 11;9(2):e87470
pubmed: 24523869
Front Psychol. 2018 Aug 03;9:1367
pubmed: 30123168
PLoS One. 2013 Oct 16;8(10):e77294
pubmed: 24146975
Accid Anal Prev. 2010 Nov;42(6):1577-84
pubmed: 20728606
Lancet. 2017 Nov 11;390(10108):2183-2193
pubmed: 28577860
Ergonomics. 2003 May 15;46(6):629-46
pubmed: 12745692
Surv Ophthalmol. 1999 May-Jun;43(6):535-50
pubmed: 10416796
Optom Vis Sci. 2015 Nov;92(11):1037-46
pubmed: 26501733
Ophthalmology. 1982 Nov;89(11):1226-34
pubmed: 7155532
Transl Vis Sci Technol. 2022 Mar 2;11(3):20
pubmed: 35297979
Am J Ophthalmol. 2007 Jun;143(6):1013-23
pubmed: 17399676
J Vis. 2013 Jul 17;13(8):
pubmed: 23863509
Ophthalmology. 2008 Feb;115(2):233-8
pubmed: 17655930
Curr Opin Ophthalmol. 2009 Mar;20(2):92-8
pubmed: 19240541
Accid Anal Prev. 2017 Apr;101:1-10
pubmed: 28161559
Behav Res Methods. 2023 Oct;55(7):3820-3830
pubmed: 36253600